Fernando de Quadros Iorra, Paula Godinho Rodrigues, Patrícia Martins Bock, Marina Petrasi Guahnon, Sarah Eller, Tiago Franco de Oliveira, Leticia Birk, Patricia de Souza Schwarz, Michele Drehmer, Katia V Bloch, Felipe Vogt Cureau, Beatriz D Schaan
{"title":"肠道微生物代谢物TMAO与青少年心脏代谢健康：横断面分析","authors":"Fernando de Quadros Iorra, Paula Godinho Rodrigues, Patrícia Martins Bock, Marina Petrasi Guahnon, Sarah Eller, Tiago Franco de Oliveira, Leticia Birk, Patricia de Souza Schwarz, Michele Drehmer, Katia V Bloch, Felipe Vogt Cureau, Beatriz D Schaan","doi":"10.1210/jendso/bvaf055","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Trimethylamine N-oxide (TMAO) is a metabolite derived from gut microbiota that has been associated with cardiovascular and metabolic disease risk in adults. However, its role in assessing cardiometabolic risk in adolescents is unclear.</p><p><strong>Objective: </strong>This study investigates the association between serum TMAO levels and cardiometabolic health indicators in Brazilian adolescents.</p><p><strong>Materials and methods: </strong>This is a multicenter, cross-sectional analysis involving 4446 participants aged 12 to 17 years from four Brazilian cities. Serum TMAO levels were quantified using liquid chromatography-tandem mass spectrometry, and associations with clinical, metabolic, and inflammatory variables were evaluated through multivariate linear regression analyses.</p><p><strong>Results: </strong>After adjusting for potential confounders, being in the highest tertile of serum TMAO was positively associated with waist circumference [β 1.45; 95% confidence interval (CI) 0.77, 2.14; <i>P</i> < .001], body mass index Z-score (β .19; 95% CI 0.10, 0.27; <i>P</i> < .001), and C-reactive protein (β .24; 95% CI 0.13, 0.34; <i>P</i> < .001). A negative association between the highest tertile of TMAO and fasting plasma glucose was also observed (β -1.22; 95% CI -1.77, -0.66; <i>P</i> < .001).</p><p><strong>Conclusion: </strong>TMAO may serve as an emerging biomarker for cardiometabolic risk assessment in adolescents.</p>","PeriodicalId":17334,"journal":{"name":"Journal of the Endocrine Society","volume":"9 5","pages":"bvaf055"},"PeriodicalIF":3.0000,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12000724/pdf/","citationCount":"0","resultStr":"{\"title\":\"Gut Microbiota Metabolite TMAO and Adolescent Cardiometabolic Health: A Cross-sectional Analysis.\",\"authors\":\"Fernando de Quadros Iorra, Paula Godinho Rodrigues, Patrícia Martins Bock, Marina Petrasi Guahnon, Sarah Eller, Tiago Franco de Oliveira, Leticia Birk, Patricia de Souza Schwarz, Michele Drehmer, Katia V Bloch, Felipe Vogt Cureau, Beatriz D Schaan\",\"doi\":\"10.1210/jendso/bvaf055\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Trimethylamine N-oxide (TMAO) is a metabolite derived from gut microbiota that has been associated with cardiovascular and metabolic disease risk in adults. However, its role in assessing cardiometabolic risk in adolescents is unclear.</p><p><strong>Objective: </strong>This study investigates the association between serum TMAO levels and cardiometabolic health indicators in Brazilian adolescents.</p><p><strong>Materials and methods: </strong>This is a multicenter, cross-sectional analysis involving 4446 participants aged 12 to 17 years from four Brazilian cities. Serum TMAO levels were quantified using liquid chromatography-tandem mass spectrometry, and associations with clinical, metabolic, and inflammatory variables were evaluated through multivariate linear regression analyses.</p><p><strong>Results: </strong>After adjusting for potential confounders, being in the highest tertile of serum TMAO was positively associated with waist circumference [β 1.45; 95% confidence interval (CI) 0.77, 2.14; <i>P</i> < .001], body mass index Z-score (β .19; 95% CI 0.10, 0.27; <i>P</i> < .001), and C-reactive protein (β .24; 95% CI 0.13, 0.34; <i>P</i> < .001). A negative association between the highest tertile of TMAO and fasting plasma glucose was also observed (β -1.22; 95% CI -1.77, -0.66; <i>P</i> < .001).</p><p><strong>Conclusion: </strong>TMAO may serve as an emerging biomarker for cardiometabolic risk assessment in adolescents.</p>\",\"PeriodicalId\":17334,\"journal\":{\"name\":\"Journal of the Endocrine Society\",\"volume\":\"9 5\",\"pages\":\"bvaf055\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-04-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12000724/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Endocrine Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1210/jendso/bvaf055\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Endocrine Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/jendso/bvaf055","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景：三甲胺n -氧化物（TMAO）是一种来自肠道微生物群的代谢物，与成人心血管和代谢性疾病的风险相关。然而，它在评估青少年心脏代谢风险中的作用尚不清楚。目的：研究巴西青少年血清氧化三甲胺水平与心脏代谢健康指标的关系。材料和方法：这是一项多中心、横断面分析，涉及来自巴西四个城市的4446名年龄在12至17岁的参与者。采用液相色谱-串联质谱法定量测定血清TMAO水平，并通过多变量线性回归分析评估其与临床、代谢和炎症变量的关系。结果：在对潜在混杂因素进行校正后，血清TMAO最高分位数与腰围呈正相关[β 1.45；95%置信区间（CI） 0.77, 2.14；P < .001]，体重指数Z-score (β .19；95% ci 0.10, 0.27；P < .001)， c反应蛋白(β .24；95% ci 0.13, 0.34；P < 0.001)。TMAO最高分位数与空腹血糖呈负相关(β -1.22；95% ci -1.77, -0.66；P < 0.001)。结论：TMAO可作为青少年心脏代谢风险评估的新兴生物标志物。
Gut Microbiota Metabolite TMAO and Adolescent Cardiometabolic Health: A Cross-sectional Analysis.
Background: Trimethylamine N-oxide (TMAO) is a metabolite derived from gut microbiota that has been associated with cardiovascular and metabolic disease risk in adults. However, its role in assessing cardiometabolic risk in adolescents is unclear.
Objective: This study investigates the association between serum TMAO levels and cardiometabolic health indicators in Brazilian adolescents.
Materials and methods: This is a multicenter, cross-sectional analysis involving 4446 participants aged 12 to 17 years from four Brazilian cities. Serum TMAO levels were quantified using liquid chromatography-tandem mass spectrometry, and associations with clinical, metabolic, and inflammatory variables were evaluated through multivariate linear regression analyses.
Results: After adjusting for potential confounders, being in the highest tertile of serum TMAO was positively associated with waist circumference [β 1.45; 95% confidence interval (CI) 0.77, 2.14; P < .001], body mass index Z-score (β .19; 95% CI 0.10, 0.27; P < .001), and C-reactive protein (β .24; 95% CI 0.13, 0.34; P < .001). A negative association between the highest tertile of TMAO and fasting plasma glucose was also observed (β -1.22; 95% CI -1.77, -0.66; P < .001).
Conclusion: TMAO may serve as an emerging biomarker for cardiometabolic risk assessment in adolescents.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
